Literature DB >> 30428097

Oxygen Diffusion May Limit the Biomechanical Effectiveness of Iontophoresis-Assisted Transepithelial Corneal Cross-linking.

Emilio A Torres-Netto, Sabine Kling, Nikki Hafezi, Paolo Vinciguerra, J Bradley Randleman, Farhad Hafezi.   

Abstract

PURPOSE: To evaluate the impact of varying treatment time on the efficacy of iontophoresis-assisted transepithelial corneal cross-linking (I-CXL) in ex vivo porcine corneas.
METHODS: One hundred twelve porcine corneas with intact epithelium were divided into 7 groups and analyzed. Groups 1, 2, and 3 received standard epitheliumoff CXL (S-CXL) with hypo-osmolaric 0.1% riboflavin and 30 minutes of ultraviolet-A (UV-A) irradiation at 3 mW/cm2, 10 minutes at 9 mW/cm2, or were not irradiated (controls). Groups 4, 5, 6, and 7 received I-CXL for either 60 minutes at 1.5 mW/cm2, 30 minutes at 3 mW/cm2, 10 minutes at 9 mW/cm2, or were not irradiated (controls). Elastic modulus and stress after relaxation of 5-mm wide corneal strips were analyzed.
RESULTS: In the S-CXL groups, significant differences (P ≤ .05) in stress-strain extensometry were found between controls and 3 mW/cm2 for 30 minutes (group 1) and between controls and 9 mW/cm2 for 10 minutes (group 2). In the I-CXL groups, only the 1.5 mW/cm2 for 60 minutes setting (group 4) showed a significant stiffening effect. All epithelium-off groups provided a stiffening effect significantly stronger than I-CXL: with a stiffening effect of 149% and 112%, groups 1 and 4 were the groups with greater elastic modulus between the S-CXL and I-CXL groups, respectively.
CONCLUSIONS: The biomechanical effect of I-CXL increased significantly when using a low irradiance/long irradiation setting. Oxygen diffusion thus represents a limiting factor even when riboflavin penetration is improved via iontophoresis. Still less effective than S-CXL, this modification may help establish transepithelial CXL as a treatment option in selected cases. [J Refract Surg. 2018;34(11):768-774.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30428097     DOI: 10.3928/1081597X-20180830-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  4 in total

Review 1.  New perspectives in keratoconus treatment: an update on iontophoresis-assisted corneal collagen crosslinking.

Authors:  Paolo Vinciguerra; Alessio Montericcio; Fiammetta Catania; Giovanni Fossati; Raffaele Raimondi; Emanuela Filomena Legrottaglie; Riccardo Vinciguerra
Journal:  Int Ophthalmol       Date:  2021-02-16       Impact factor: 2.031

2.  Corneal Cross-linking for Keratoconus: Exploring the Issues Regarding Accelerated Protocols and Thin Corneas.

Authors:  Farhad Hafezi
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

3.  Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus.

Authors:  Kenneth A Beckman
Journal:  Clin Ophthalmol       Date:  2021-07-07

4.  Safety and efficacy of repeated crosslinking assisted by transepithelial double-cycle iontophoresis in keratoconus progression after primary corneal crosslinking.

Authors:  Huping Wu; Lan Li; Shunrong Luo; Xie Fang; Xumin Shang; Zhiwen Xie; Xianwen Xiao; Huan He; Zhirong Lin; Zuguo Liu
Journal:  Eye (Lond)       Date:  2021-01-07       Impact factor: 4.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.